Home › IPO GMP › Himalaya Nutravedics India

Himalaya Nutravedics India IPO GMP Today, Grey Market Premium & Expected Listing Price

A reliable grey-market quote has not built up yet for this issue. This page updates automatically through the bidding window.

Himalaya Nutravedics India IPO GMP story: what the numbers say

Books show 2.33x total subscription (QIB 1.0x, NII 3.58x, retail 2.56x). Retail is doing the heavy lifting here while institutional books stay thin — premiums built on retail-only heat fade faster into close day. This is an SME issue on NSE Emerge/BSE SME — thinner grey-market depth than mainboard, so small dealer shifts move the quote more. The ₹127,200+ minimum ticket keeps small savers out, so SME grey quotes swing harder on fewer hands. This issue has already listed — compare the debut against the premium trail above to judge how honest the street signal was.

Unofficial street quote — treat as sentiment alongside subscription breadth and fundamentals, never as a promised listing price.

Grey Market Premium is an unofficial, off-exchange quote. SEBI does not recognise grey-market trading; the actual listing price is decided by order-book demand on debut day.

Himalaya Nutravedics India IPO Key Facts

Price Band₹100 - ₹106
Lot Size1,200 shares
Issue Size₹26 Cr
Opening Date22 Sep 2026
Closing Date24 Sep 2026
Listing Date29 Sep 2026
Subscription2.33x

Frequently Asked Questions

What is Himalaya Nutravedics India IPO GMP today?

The latest unofficial grey market premium for Himalaya Nutravedics India IPO is not yet available. This page updates automatically through the bidding window.

Why does Himalaya Nutravedics India IPO GMP move every day?

GMP is re-quoted through the bidding window as subscription momentum and market mood shift. No quote yet for this issue — this page updates automatically.

Is GMP a guarantee of listing gains?

No. GMP is an unofficial sentiment indicator that can change quickly. The actual listing price is decided by regular order-book demand on the exchanges on debut day. For Himalaya Nutravedics India, the book stands at 2.33x overall with QIB demand at 1.0x — read that breadth next to the premium, not the premium alone.

Where can I check the full Himalaya Nutravedics India IPO analysis?

The full report with subscription status, RHP financials, strengths and data-based analysis signal is on the Himalaya Nutravedics India IPO detail page.

Disclaimer: Informational only; DostIpo is not a SEBI-registered adviser. GMP figures are unofficial estimates, not investment advice.

Read the full Himalaya Nutravedics India IPO report →

More on This IPO

Other IPOs — Live Gmp Pages

Last updated: 14 Oct 2026, 02:21 IST